Maximising glaucoma treatment outcomes
Fixed combinations of IOP-lowering medications provide several advantages in clinical practice over unfixed combinations.
Cheryl Guttman Krader
Published: Thursday, March 23, 2017
Approximately half of patients with open-angle glaucoma need more than one medication to reach target IOP.“Some doctors only know the commercial brand name of the fixed combination. If they cannot make an educated guess about a causal relationship with one of its ingredients, it will be necessary to stop the fixed combination and restart therapy, building it up in a stepwise manner,” he said. Cost may also be lower with a fixed combination product. Dr Holló said the limitations of fixed combination drops are minor compared with the benefits. Although IOP reduction in controlled comparative trials was greater using two drugs as an unfixed combination than as a fixed combination, the difference was minimal, and not clinically significant. Another downside of fixed combinations is that they limit dosing flexibility. Dr Holló suggested, however, this issue is only rarely important. “Special attention may be required for a patient who needs smoothing of a funny IOP spike during the day, and in that situation we cannot use the fixed combination,” he explained.
Tags: glaucoma, medication
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.